ESPRIT¿
Report
- Report Number
- 2024168-2026-01342
- Event Type
- Injury
- Date Received
- April 1, 2026
- Date of Event
- February 27, 2026
- Report Date
- April 1, 2026
- Manufacturer
- ABBOTT VASCULAR INC.
- Product Code
- NXW
- UDI-DI
- 08717648357473
- PMA / PMN Number
- P230036
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SZ
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THE DEVICE WAS NOT RETURNED FOR ANALYSIS. PRODUCTION RECORD AND CORRECTIVE AND PREVENTATIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. ADDITIONALLY, A QUERY OF THE COMPLAINT HANDLING DATABASE FOR THE REPORTED LOT REVEALED THERE IS NO INDICATION OF A LOT SPECIFIC ISSUE. THE REPORTED PATIENT EFFECT OF OCCLUSION IS LISTED IN THE ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY SCAFFOLDING PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT, AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. B3: DATE OF EVENT ESTIMATED. THE ADDITIONAL DEVICE MENTIONED IN B5 WILL BE FILED UNDER A SEPARATE MEDWATCH REPORT.
IT WAS REPORTED THE INITIAL PROCEDURE WAS PERFORMED ON (B)(6) 2025 WHERE TWO 3.50X28 ESPRIT BTK SCAFFOLDS WERE IMPLANTED OVERLAPPING IN THE ANTERIOR TIBIAL ARTERY WITHOUT ISSUE. PATIENT HAD GOOD INFLOW AFTER IMPLANTATION WITH GOOD OUTFLOW TO THE FOOT. AT THE THREE MONTH FOLLOW UP IT WAS NOTED BOTH OF THE SCAFFOLDS HAD OCCLUDED. NO TREATMENT WAS PERFORMED AS THE WOUND WAS ALREADY HEALING. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 472268 | ESPRIT¿ | STENT, INFRAPOPLITEAL, ABSORBABLE | NXW | ABBOTT VASCULAR INC. | ESPRIT BTK | 5080661 | 08717648357473 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |